Renal medullary carcinoma
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Renal medullary carcinoma | |
|---|---|
| Micrograph of renal medullary carcinoma | |
| Synonyms | RMC |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hematuria, flank pain, weight loss, fever |
| Complications | Metastasis, renal failure |
| Onset | Typically in adolescence or young adulthood |
| Duration | Progressive |
| Types | |
| Causes | Associated with sickle cell trait |
| Risks | Sickle cell trait, African descent |
| Diagnosis | Histopathology, imaging studies |
| Differential diagnosis | Renal cell carcinoma, urothelial carcinoma |
| Prevention | |
| Treatment | Chemotherapy, surgery |
| Medication | |
| Prognosis | Poor |
| Frequency | Rare |
| Deaths | N/A |
Renal medullary carcinoma is a rare type of kidney cancer that primarily affects young adults and is associated with sickle cell trait. This cancer is aggressive and is often diagnosed at an advanced stage.
Symptoms[edit]
The symptoms of renal medullary carcinoma can vary, but may include:
- Blood in the urine (hematuria)
- Abdominal pain
- Weight loss
- Anemia
Causes[edit]
Renal medullary carcinoma is associated with sickle cell trait. This is a condition in which a person has one abnormal hemoglobin gene and one normal hemoglobin gene. It is not the same as sickle cell disease, which is a serious disorder in which the body makes sickle-shaped red blood cells.
Diagnosis[edit]
Diagnosis of renal medullary carcinoma can be challenging due to its rarity. It is often diagnosed through a combination of imaging tests, such as CT scans or MRIs, and a biopsy of the tumor.
Treatment[edit]
Treatment for renal medullary carcinoma typically involves a combination of surgery, chemotherapy, and radiation therapy. However, due to the aggressive nature of this cancer, it is often diagnosed at an advanced stage when treatment is less likely to be successful.
Prognosis[edit]
The prognosis for renal medullary carcinoma is generally poor, with a median survival time of less than a year. However, survival can vary depending on factors such as the stage of the cancer at diagnosis and the patient's overall health.
See also[edit]
| Tumors of the urinary and genital systems | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
 | This medical article is a stub. You can help WikiMD by expanding the page. |
